Skip to content
DefDex

Federal award

AMERISOURCEBERGEN DRUG CORP

SPE2DX15D6000

Contract vehicle (IDV)IDV: ceiling is not spending

Obligated and Ceiling

Obligated (net)
$0.00
Vehicle ceiling (not spending)
$779,900,811.00
Current value
—
Gross positive obligations
$0.00

Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.

Award Details

Recipient
AMERISOURCEBERGEN DRUG CORP · KABZK8W6PQT3
Owner company
Not a reviewed companyNo reviewed company owns this recipient.
Reported parent
CENCORA GLOBAL CONSULTING SERVICES US CORP · GTXTRMLFL9U7
Awarding agency
Department of Defense · sub-agency 97AS · office SPE2DX
Funding agency
Department of Defense · sub-agency 97AS
Product or service (PSC)
6505 · DRUGS AND BIOLOGICALS
Industry (NAICS)
325411 · MEDICINAL AND BOTANICAL MANUFACTURING
PIID
SPE2DX15D6000
Award type code
B
Actions
14 · Nov 13, 2014 to Jan 30, 2025
Why it is listed
contract vehicle (IDV)

Open this award on USAspending →

Action History14

Award actions
DateFYModAction typeObligationCompany in company totals
Jan 30, 2025FY2025P00015D$0.00
—
Dec 19, 2024FY2025P00014D$0.00
—
Apr 24, 2024FY2024P00013B$0.00
—
Jul 10, 2023FY2023P00012D$0.00
—
Aug 18, 2022FY2022P00010M$0.00
—
Sep 27, 2021FY2021P00009M$0.00
—
Sep 24, 2020FY2020P00008M$0.00
—
Aug 28, 2019FY2019P00007M$0.00
—
Aug 27, 2019FY2019P00006B$0.00
—
Jan 17, 2019FY2019P00005B$0.00
—
Nov 29, 2018FY2019P00004B$0.00
—
Aug 29, 2017FY2017P00003B$0.00
—
Mar 30, 2017FY2017P00002B$0.00
—
Nov 13, 2014FY20150—$0.00
—

Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.